Identification
Instrument name
ONCODESIGN
Symbol
ALONC
ISIN code
FR0011766229
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description

<p>
Oncodesign specializes in the research and development of drugs for the treatment of cancer. The group provides preclinical pharmacological evaluation services in the oncology field.<br />
<em>Source: Cofisem</em></p>

Operation
IPO date
IPO type

<p>
Initial Public Offering</p>

IPO price
7,34 EUR
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 6.42 - EUR 7.34
Capital raised
12.8